nodes	percent_of_prediction	percent_of_DWPC	metapath
Aceprometazine—HRH1—Histamine receptors—HRH3—attention deficit hyperactivity disorder	0.16	0.19	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—ADRA2C—attention deficit hyperactivity disorder	0.0435	0.0518	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—DRD5—attention deficit hyperactivity disorder	0.0426	0.0507	CbGpPWpGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—ADRA2C—attention deficit hyperactivity disorder	0.0366	0.0435	CbGpPWpGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—DRD5—attention deficit hyperactivity disorder	0.0358	0.0426	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—HTR1B—attention deficit hyperactivity disorder	0.0258	0.0307	CbGpPWpGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—HRH3—attention deficit hyperactivity disorder	0.0248	0.0296	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—DRD1—attention deficit hyperactivity disorder	0.024	0.0286	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—DRD3—attention deficit hyperactivity disorder	0.0233	0.0277	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—ADRA2A—attention deficit hyperactivity disorder	0.0229	0.0272	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—DRD4—attention deficit hyperactivity disorder	0.0226	0.0269	CbGpPWpGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—HTR1B—attention deficit hyperactivity disorder	0.0217	0.0258	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—DRD2—attention deficit hyperactivity disorder	0.021	0.025	CbGpPWpGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—DRD1—attention deficit hyperactivity disorder	0.0202	0.024	CbGpPWpGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—DRD3—attention deficit hyperactivity disorder	0.0195	0.0233	CbGpPWpGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—ADRA2A—attention deficit hyperactivity disorder	0.0192	0.0229	CbGpPWpGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—DRD4—attention deficit hyperactivity disorder	0.019	0.0226	CbGpPWpGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—DRD2—attention deficit hyperactivity disorder	0.0177	0.021	CbGpPWpGaD
Aceprometazine—HRH1—Monoamine GPCRs—HTR2A—attention deficit hyperactivity disorder	0.0147	0.0175	CbGpPWpGaD
Aceprometazine—HRH1—Amine ligand-binding receptors—HTR2A—attention deficit hyperactivity disorder	0.0124	0.0147	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2C—attention deficit hyperactivity disorder	0.0084	0.00999	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD5—attention deficit hyperactivity disorder	0.00823	0.00979	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—GRM7—attention deficit hyperactivity disorder	0.00817	0.00972	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2C—attention deficit hyperactivity disorder	0.00719	0.00856	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD5—attention deficit hyperactivity disorder	0.00705	0.00839	CbGpPWpGaD
Aceprometazine—Diltiazem—CACNA1C—attention deficit hyperactivity disorder	0.0058	0.0363	CrCbGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—HRH3—attention deficit hyperactivity disorder	0.0057	0.00678	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—ADRA2C—attention deficit hyperactivity disorder	0.00548	0.00652	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—DRD5—attention deficit hyperactivity disorder	0.00537	0.00639	CbGpPWpGaD
Aceprometazine—Acetophenazine—DRD1—attention deficit hyperactivity disorder	0.00527	0.033	CrCbGaD
Aceprometazine—HRH1—IL-4 Signaling Pathway—EP300—attention deficit hyperactivity disorder	0.00526	0.00626	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR1B—attention deficit hyperactivity disorder	0.00498	0.00593	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HRH3—attention deficit hyperactivity disorder	0.00488	0.00581	CbGpPWpGaD
Aceprometazine—Methotrimeprazine—DRD5—attention deficit hyperactivity disorder	0.00472	0.0296	CrCbGaD
Aceprometazine—Propericiazine—DRD1—attention deficit hyperactivity disorder	0.00465	0.0291	CrCbGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD1—attention deficit hyperactivity disorder	0.00463	0.00551	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—GRM7—attention deficit hyperactivity disorder	0.00462	0.00549	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD3—attention deficit hyperactivity disorder	0.00449	0.00534	CbGpPWpGaD
Aceprometazine—Methotrimeprazine—ADRA2C—attention deficit hyperactivity disorder	0.00445	0.0279	CrCbGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—ADRA2A—attention deficit hyperactivity disorder	0.00441	0.00525	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—attention deficit hyperactivity disorder	0.00436	0.00518	CbGpPWpGaD
Aceprometazine—Propericiazine—ADRA2A—attention deficit hyperactivity disorder	0.00433	0.0271	CrCbGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	0.00427	0.00508	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	0.00419	0.00499	CbGpPWpGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—DRD2—attention deficit hyperactivity disorder	0.00406	0.00483	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	0.00397	0.00472	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	0.00384	0.00457	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	0.00378	0.0045	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	0.00373	0.00444	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	0.00372	0.00443	CbGpPWpGaD
Aceprometazine—Acetophenazine—DRD2—attention deficit hyperactivity disorder	0.00371	0.0233	CrCbGaD
Aceprometazine—HRH1—G alpha (q) signalling events—HTR2A—attention deficit hyperactivity disorder	0.00368	0.00438	CbGpPWpGaD
Aceprometazine—Chlorpromazine—DRD5—attention deficit hyperactivity disorder	0.0036	0.0225	CrCbGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	0.00348	0.00414	CbGpPWpGaD
Aceprometazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—attention deficit hyperactivity disorder	0.00329	0.00391	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	0.00325	0.00387	CbGpPWpGaD
Aceprometazine—Triflupromazine—DRD1—attention deficit hyperactivity disorder	0.00323	0.0202	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	0.0031	0.00368	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	0.00303	0.00361	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	0.00302	0.0036	CbGpPWpGaD
Aceprometazine—Acepromazine—DRD1—attention deficit hyperactivity disorder	0.00299	0.0187	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	0.00293	0.00348	CbGpPWpGaD
Aceprometazine—Thioproperazine—DRD1—attention deficit hyperactivity disorder	0.00292	0.0183	CrCbGaD
Aceprometazine—Mesoridazine—DRD3—attention deficit hyperactivity disorder	0.00289	0.0181	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	0.00288	0.00342	CbGpPWpGaD
Aceprometazine—Pipotiazine—DRD1—attention deficit hyperactivity disorder	0.00288	0.018	CrCbGaD
Aceprometazine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	0.00284	0.00338	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	0.00284	0.00338	CbGpPWpGaD
Aceprometazine—Propiomazine—DRD4—attention deficit hyperactivity disorder	0.00282	0.0177	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	0.00281	0.00335	CbGpPWpGaD
Aceprometazine—Prochlorperazine—DRD3—attention deficit hyperactivity disorder	0.0028	0.0175	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	0.00275	0.00328	CbGpPWpGaD
Aceprometazine—HRH1—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	0.00265	0.00315	CbGpPWpGaD
Aceprometazine—Cyamemazine—HTR2A—attention deficit hyperactivity disorder	0.00254	0.0159	CrCbGaD
Aceprometazine—Fluphenazine—DRD3—attention deficit hyperactivity disorder	0.00253	0.0159	CrCbGaD
Aceprometazine—Fluphenazine—DRD1—attention deficit hyperactivity disorder	0.00249	0.0156	CrCbGaD
Aceprometazine—HRH1—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	0.00248	0.00295	CbGpPWpGaD
Aceprometazine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	0.00243	0.0029	CbGpPWpGaD
Aceprometazine—Methotrimeprazine—DRD4—attention deficit hyperactivity disorder	0.00242	0.0151	CrCbGaD
Aceprometazine—Propiomazine—DRD1—attention deficit hyperactivity disorder	0.00239	0.015	CrCbGaD
Aceprometazine—Fluphenazine—ADRA2A—attention deficit hyperactivity disorder	0.00231	0.0145	CrCbGaD
Aceprometazine—Chlorprothixene—DRD3—attention deficit hyperactivity disorder	0.00231	0.0144	CrCbGaD
Aceprometazine—Triflupromazine—DRD2—attention deficit hyperactivity disorder	0.00228	0.0143	CrCbGaD
Aceprometazine—Chlorprothixene—DRD1—attention deficit hyperactivity disorder	0.00226	0.0142	CrCbGaD
Aceprometazine—Thioridazine—DRD1—attention deficit hyperactivity disorder	0.00214	0.0134	CrCbGaD
Aceprometazine—Clomipramine—ADRA2A—attention deficit hyperactivity disorder	0.00211	0.0132	CrCbGaD
Aceprometazine—Acepromazine—DRD2—attention deficit hyperactivity disorder	0.00211	0.0132	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	0.0021	0.0025	CbGpPWpGaD
Aceprometazine—Promazine—DRD4—attention deficit hyperactivity disorder	0.00209	0.0131	CrCbGaD
Aceprometazine—Methotrimeprazine—DRD3—attention deficit hyperactivity disorder	0.00208	0.013	CrCbGaD
Aceprometazine—Thioproperazine—DRD2—attention deficit hyperactivity disorder	0.00206	0.0129	CrCbGaD
Aceprometazine—Methotrimeprazine—DRD1—attention deficit hyperactivity disorder	0.00204	0.0128	CrCbGaD
Aceprometazine—Pipotiazine—DRD2—attention deficit hyperactivity disorder	0.00203	0.0127	CrCbGaD
Aceprometazine—Mesoridazine—DRD2—attention deficit hyperactivity disorder	0.002	0.0125	CrCbGaD
Aceprometazine—Thioridazine—ADRA2A—attention deficit hyperactivity disorder	0.00199	0.0125	CrCbGaD
Aceprometazine—Trimipramine—SLC6A3—attention deficit hyperactivity disorder	0.00198	0.0124	CrCbGaD
Aceprometazine—Perphenazine—DRD1—attention deficit hyperactivity disorder	0.00197	0.0123	CrCbGaD
Aceprometazine—Trimipramine—ADRA2A—attention deficit hyperactivity disorder	0.00194	0.0122	CrCbGaD
Aceprometazine—Prochlorperazine—DRD2—attention deficit hyperactivity disorder	0.00194	0.0121	CrCbGaD
Aceprometazine—HRH1—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	0.00193	0.0023	CbGpPWpGaD
Aceprometazine—HRH1—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	0.00191	0.00227	CbGpPWpGaD
Aceprometazine—Methotrimeprazine—ADRA2A—attention deficit hyperactivity disorder	0.0019	0.0119	CrCbGaD
Aceprometazine—HRH1—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	0.00185	0.00221	CbGpPWpGaD
Aceprometazine—Chlorpromazine—DRD4—attention deficit hyperactivity disorder	0.00184	0.0115	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	0.00184	0.00219	CbGpPWpGaD
Aceprometazine—Perphenazine—ADRA2A—attention deficit hyperactivity disorder	0.00183	0.0114	CrCbGaD
Aceprometazine—Promazine—DRD1—attention deficit hyperactivity disorder	0.00177	0.0111	CrCbGaD
Aceprometazine—Fluphenazine—DRD2—attention deficit hyperactivity disorder	0.00175	0.011	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	0.00171	0.00203	CbGpPWpGaD
Aceprometazine—Propiomazine—DRD2—attention deficit hyperactivity disorder	0.00169	0.0106	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	0.00167	0.00199	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	0.00166	0.00198	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	0.00165	0.00197	CbGpPWpGaD
Aceprometazine—Promazine—ADRA2A—attention deficit hyperactivity disorder	0.00165	0.0103	CrCbGaD
Aceprometazine—Acepromazine—HTR2A—attention deficit hyperactivity disorder	0.00163	0.0102	CrCbGaD
Aceprometazine—HRH1—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	0.00163	0.00194	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	0.00163	0.00194	CbGpPWpGaD
Aceprometazine—Clomipramine—SLC6A4—attention deficit hyperactivity disorder	0.00161	0.0101	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	0.00161	0.00191	CbGpPWpGaD
Aceprometazine—Chlorprothixene—DRD2—attention deficit hyperactivity disorder	0.0016	0.00999	CrCbGaD
Aceprometazine—HRH1—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	0.0016	0.0019	CbGpPWpGaD
Aceprometazine—Thioproperazine—HTR2A—attention deficit hyperactivity disorder	0.00159	0.00997	CrCbGaD
Aceprometazine—Chlorpromazine—DRD3—attention deficit hyperactivity disorder	0.00159	0.00995	CrCbGaD
Aceprometazine—Pipotiazine—HTR2A—attention deficit hyperactivity disorder	0.00157	0.00981	CrCbGaD
Aceprometazine—Chlorpromazine—DRD1—attention deficit hyperactivity disorder	0.00156	0.00976	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	0.00155	0.00185	CbGpPWpGaD
Aceprometazine—Mesoridazine—HTR2A—attention deficit hyperactivity disorder	0.00155	0.00968	CrCbGaD
Aceprometazine—Thioridazine—DRD2—attention deficit hyperactivity disorder	0.00151	0.00945	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	0.0015	0.00179	CbGpPWpGaD
Aceprometazine—HRH1—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	0.0015	0.00178	CbGpPWpGaD
Aceprometazine—Trimipramine—SLC6A4—attention deficit hyperactivity disorder	0.00148	0.00928	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	0.00148	0.00176	CbGpPWpGaD
Aceprometazine—Trimipramine—DRD2—attention deficit hyperactivity disorder	0.00147	0.00923	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	0.00146	0.00174	CbGpPWpGaD
Aceprometazine—Chlorpromazine—ADRA2A—attention deficit hyperactivity disorder	0.00145	0.00907	CrCbGaD
Aceprometazine—Methotrimeprazine—DRD2—attention deficit hyperactivity disorder	0.00144	0.00902	CrCbGaD
Aceprometazine—Promethazine—DRD2—attention deficit hyperactivity disorder	0.00142	0.00889	CrCbGaD
Aceprometazine—Trifluoperazine—DRD2—attention deficit hyperactivity disorder	0.0014	0.00877	CrCbGaD
Aceprometazine—Perphenazine—DRD2—attention deficit hyperactivity disorder	0.00139	0.00867	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	0.00136	0.00162	CbGpPWpGaD
Aceprometazine—Fluphenazine—HTR2A—attention deficit hyperactivity disorder	0.00135	0.00848	CrCbGaD
Aceprometazine—Propiomazine—HTR2A—attention deficit hyperactivity disorder	0.0013	0.00815	CrCbGaD
Aceprometazine—Promazine—DRD2—attention deficit hyperactivity disorder	0.00125	0.00782	CrCbGaD
Aceprometazine—Clomipramine—HTR2A—attention deficit hyperactivity disorder	0.00124	0.00775	CrCbGaD
Aceprometazine—Chlorprothixene—HTR2A—attention deficit hyperactivity disorder	0.00123	0.00772	CrCbGaD
Aceprometazine—Thioridazine—HTR2A—attention deficit hyperactivity disorder	0.00117	0.0073	CrCbGaD
Aceprometazine—Trimipramine—HTR2A—attention deficit hyperactivity disorder	0.00114	0.00713	CrCbGaD
Aceprometazine—HRH1—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	0.00113	0.00134	CbGpPWpGaD
Aceprometazine—Methotrimeprazine—HTR2A—attention deficit hyperactivity disorder	0.00111	0.00697	CrCbGaD
Aceprometazine—Chlorpromazine—DRD2—attention deficit hyperactivity disorder	0.0011	0.00688	CrCbGaD
Aceprometazine—Promethazine—HTR2A—attention deficit hyperactivity disorder	0.0011	0.00687	CrCbGaD
Aceprometazine—Trifluoperazine—HTR2A—attention deficit hyperactivity disorder	0.00108	0.00678	CrCbGaD
Aceprometazine—Perphenazine—HTR2A—attention deficit hyperactivity disorder	0.00107	0.0067	CrCbGaD
Aceprometazine—HRH1—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	0.00105	0.00125	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	0.000986	0.00117	CbGpPWpGaD
Aceprometazine—Promazine—HTR2A—attention deficit hyperactivity disorder	0.000965	0.00604	CrCbGaD
Aceprometazine—HRH1—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	0.000952	0.00113	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	0.000916	0.00109	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	0.000887	0.00106	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	0.000872	0.00104	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	0.000862	0.00103	CbGpPWpGaD
Aceprometazine—Chlorpromazine—HTR2A—attention deficit hyperactivity disorder	0.000849	0.00532	CrCbGaD
Aceprometazine—HRH1—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	0.000803	0.000955	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	0.000562	0.000669	CbGpPWpGaD
Aceprometazine—HRH1—Signaling Pathways—EP300—attention deficit hyperactivity disorder	0.000298	0.000354	CbGpPWpGaD
